Invokanahcp.com

INVOKANA® (canagliflozin) Treatment HCP

WebThe only T2D pill approved to reduce the risk of heart attack, stroke, and cardiovascular death1,2. In those with T2D and established CVD. Start with early reductions* in A1C, …

Actived: 6 days ago

URL: https://www.invokanahcp.com/homepage

INVOKANA® (canagliflozin) Official Website HCP

WebThe most common adverse reactions (5% or greater incidence) were female genital mycotic infections, urinary tract infections, and increased urination. Please read full Prescribing …

Category:  Health Go Health

Educational Resources for HCPs INVOKANA® (canagliflozin) HCP

WebINVOKANA® educational resources to help support you and. your practice. Downloadable resources. Guide to Prior Authorization Forms. A reference for completing prior …

Category:  Health Go Health

Coverage Finder INVOKANA® (canagliflozin) HCP

WebFind coverage information for patients in your area. Janssen is dedicated to making INVOKANA® affordable and accessible for all patients. INVOKANA® is accessible with …

Category:  Health Go Health

The FIRST T2D therapy approved by the FDA to reduce the …

Web3 Sample prior authorization form WARNINGS AND PRECAUTIONS, continued • Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis …

Category:  Health Go Health

Savings and Support INVOKANA® (canagliflozin) HCP

WebSupport for patients using government-funded healthcare programs or patients without insurance coverage: Call a Janssen CarePath Care Coordinator at 877-CarePath (877 …

Category:  Health Go Health

The FIRST T2D therapy approved by the FDA to reduce the …

Web3 Sample prior authorization form WARNINGS AND PRECAUTIONS, continued • Lower-Limb Amputation (continued): Lower-limb infections, gangrene, and diabetic foot ulcers …

Category:  Health Go Health

Medical Information Center InvokanaHCP

WebFor patients with eGFR ≥60 mL/min/1.73 m 2, if an inducer of UGTs is administered with INVOKANA ®, increase the dosage to 200 mg daily (taken as two 100-mg tablets) in …

Category:  Health Go Health

HHF Benefit INVOKANA® (canagliflozin) HCP

WebTo reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke) in adults with type 2 diabetes mellitus and …

Category:  Health Go Health

MACE Benefit INVOKANA® (canagliflozin) HCP

WebIn the longest CV outcomes trial of any SGLT2i, INVOKANA® demonstrated an early and sustained (up to 6.5 years) relative risk reduction ‡ of 3-point MACE for patients with …

Category:  Health Go Health